This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
F. Knoop, Der Abbau aromatischer Fettsaeuren im Tierkoerper, Beitr chem Physiol Pathol 6, 150–162 (1904).
H. Winterstein, Ueber die Sauerstoffatmung des isolierten Saeugetierherzens, Z Allg Physiol 4, 339–359 (1904).
R. J. Bing, A. Siegel, I. Ungar, and M. Gilbert, Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism, Am J Med 16, 504–15 (1954).
F. L. Holmes, Between Biology and Medicine: The Formation of Intermediary Metabolism. Berkeley, CA: University of California at Berkeley; p. 114 (1992).
P. J. Randle, P. B. Garland, C. N. Hales, and E. A. Newsholme, The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet 1, 785–789 (1963).
H. Taegtmeyer, R. Hems, and H. A. Krebs, Utilization of energy providing substrates in the isolated working rat heart, Biochem J 186, 701–711 (1980).
J. D. McGany, S. E. Mills, C. S. Long, and D.W. Foster, Observations on the affinity for carnitine and malonyl-CoA sensitivity of carnitine palmitoyl transferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat, Biochem J 214, 21–28 (1983).
M. E. Young, G. W. Goodwin, J. Ying, P. Guthrie, C. R. Wilson, F. A. Laws, and H. Taegtmeyer, Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids, Am J Physiol Endocrinol Metab 280, E471–E479 (2001).
D. G. Hardie, and D. Carling, The AMP-activated protein kinase—fuel gauge of the mammalian cell? Eur J Biochem 246, 259–273 (1997).
N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters, Malonyl-CoA, fuel sensing, and insulin resistance, Am J Physiol 276, E1–E18 (1999).
P. M. Barger, J. M. Brandt, T. C. Leone, C. J. Weinheimer, and D. P. Kelly, Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth, J Clin Invest 105, 1723–1730 (2000).
M. F. Allard, B. O. Schonekess, S. L. Henning, D. R. English, and G. D. Lopaschuk, Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts, Am J Physiol 267, H742–H750 (1994).
T. Doenst, G. W. Goodwin, A. M. Cedars, M. Wang, S. Stepkowski, and H. Taegtmeyer, Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro, Metabolism 50, 1083–1090 (2001).
M. E. Young, S. Patil, J. Ying, C. Depre, H. S. Ahuja, G. L. Shipley, S. M. Stepkowski, P. J. Davies and H. Taegtmeyer, Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart, FASEB J 15, 833–845 (2001).
G. W. Goodwin, C. S. Taylor, and H. Taegtmeyer, Regulation of energy metabolism of the heart during acute increase in heart work, J Biol Chem 273, 29530–29539 (1998).
H. Taegtmeyer, Genetics of energetics: transcriptional responses in cardiac metabolism, Ann Biomed Eng 28, 871–876 (2000).
P. M. Barger, and D. P. Kelly, PPAR signaling in the control of cardiac energy metabolism, Trends Cardiovasc Med 10, 238–45 (2000).
D. P. Kelly, PPARs of the heart: three is a crowd, Circ Res 92, 482–4 (2003).
J. J. Lehman, and D. P. Kelly, Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth, Heart Fail Rev 7, 175–85 (2002).
C. Depre, G. L. Shipley, W. Chen, Q. Han, T. Doenst, M. L. Moore, S. Stepkowski, P. J. Davies and H. Taegtmeyer, Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy, Nature Medicine 4, 1269–1275 (1998).
P. Razeghi, M. E. Young, S. Abbasi, and H. Taegtmeyer, Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart, Biochem Biophys Res Commun 287, 5–10 (2001).
M. E. Young, P. Guthrie, S. Stepkowski, and H. Taegtmeyer, Glucose regulation of sarcomeric protein gene expression in the rat heart, J Mol Cell Cardiol 33, A181 (abstract) (2001).
S. Bishop, and R. Altschuld, Increased glycolytic metabolism in cardiac hypertrophy and congestive heart failure, Am J Physiol 218, 153–159 (1970).
H. Taegtmeyer, and M. L. Overturf, Effects of moderate hypertension on cardiac function and metabolism in the rabbit, Hypertension 11, 416–426 (1988).
B. Wittels, and J. F. Spann, Defective lipid metabolism in the failing heart, J Clin Invest 47, 1787–1794 (1968).
M. N. Sack, T. A. Rader, S. Park, J. Bastin, S. A. McCune, and D. P. Kelly, Fatty acid oxidation enzyme gene expression is downregulated in the failing heart, Circulation 94, 2837–2842 (1996).
V. G. Davila-Roman, G. Vedala, P. Herrero, L. de las Fuentes, J. G. Rogers, D. P. Kelly and R. J. Gropler, Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy, J Am Coll Cardiol 40, 271–7 (2002).
H. Taegtmeyer, S. Sharma, L. Golfman, M. Van Arsdall, and P. Razeghi, Linking gene expression to function: metabolic flexibility in normal and diseased heart, Ann N Y Acad Sci 1015, 1–12 (2004).
L. A. Nikolaidis, A. Sturzu, C. Stolarski, D. Elahi, Y. T. Shen, and R. P. Shannon, The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy, Cardiovasc Res 61, 297–306 (2004).
M. E. Young, P. McNulty, and H. Taegtmeyer, Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms, Circulation 105, 1861–1870 (2002).
P. Ferre, Regulation of gene expression by glucose, Proc Nutr Soc 58, 621–3 (1999).
K. Uyeda, H. Yamashita, and T. Kawaguchi, Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage, Biochem Pharmacol 63, 2075–80 (2002).
J. Girard, P. Ferre, and F. Foufelle, Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes, Annu Rev Nutr 17, 325–352 (1997).
M. Maki, M. Luotolahti, P. Nuutila, H. Iida, L. Voipio-Pulkki, U Ruotsalainen, M. Haaparanta, O. Solin, J. Hartiala, R. Harkonen and J. Knuuti, Glucose uptake in the chronically dysfunctional but viable myocardium, Circulation 93, 1658–66 (1996).
C. Depre, J. L. Vanoverschelde, B. Gerber, M. Borgers, J. A. Melin, and R. Dion, Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting, J Thorac Cardiovasc Surg 113, 82–87 (1997).
C. Depre, and H. Taegtmeyer, Metabolic aspects of programmed cell survival and cell death in the heart, Cardiovasc Res 45, 538–548 (2000).
R. A. Gottlieb, Mitochondria: ignition chamber for apoptosis, Mol Genet Metab 68, 227–231 (1999).
J. Downward, Metabolism meets death, Nature 424, 896–7 (2003).
O. Warburg, On the origin of cancer cells, Science 123, 309–314 (1956).
D. Hanahan, and R. A. Weinberg, The Hallmarks of cancer, Cell 100, 57–70 (2000).
J. A. Fallavollita, B. J. Malm, and J. M. J. Canty, Hibernating myocardiam retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest, Circ Res 92, 48–55 (2003).
M. N. Sack, and D. M. Yellon, Insulin Therapy as an Adjunct to Reperfusion After Acute Coronary Ischemia, A Proposed Direct Myocardial Cell Survival Effect Independent of Metabolic Modulation, J Am Coll Cardiol 41, 1404–07 (2003).
T. Matsui, T. Nagoshi, and A. Rosenzweig, Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival, Cell Cycle 2, 220–3 (2003).
T. Matsui, L. Li, J. Wu, S. Cook, T. Nagoshi, M. Picard, R. Liao and A. Rosenzweig, Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart, J Biol Chem 277, 22896–901 (2002).
E. Whiteman, H. Cho, and M. Birnbaum, Role of Akt/protein kinase B in metabolism, Trends Endocrinol Metab 13, 444–51 (2002).
K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R. B. Robey, and N. Hay, Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase, Genes Dev 15, 1406–1418 (2001).
N. Majewski, V. Nogueira, R. B. Robey, and N. Hay, Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases, Mol Cell Biol 24, 730–40 (2004).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Taegtmeyer, H. (2006). From Fetal to Fatal. In: Cokkinos, D.V., Pantos, C., Heusch, G., Taegtmeyer, H. (eds) Myocardial Ischemia. Basic Science for the Cardiologist, vol 21. Springer, Boston, MA. https://doi.org/10.1007/0-387-28658-6_1
Download citation
DOI: https://doi.org/10.1007/0-387-28658-6_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28657-0
Online ISBN: 978-0-387-28658-7
eBook Packages: MedicineMedicine (R0)